CymitQuimica logo

CAS 1859141-26-6

:

ROC-325

Description:
As of my last update in October 2023, specific information about the chemical substance ROC-325 with the CAS number 1859141-26-6 is limited in publicly available databases. Generally, substances with such identifiers are often in the research or development phase, potentially serving as pharmaceutical compounds or intermediates in chemical synthesis. Characteristics of such compounds typically include their molecular structure, functional groups, solubility, stability, and reactivity, which are crucial for understanding their behavior in various environments. Additionally, safety data, including toxicity and handling precautions, would be essential for any practical applications. For precise details, including physical and chemical properties, it is advisable to consult specialized chemical databases, scientific literature, or safety data sheets provided by manufacturers or research institutions.
Formula:C28H27ClN4OS
Synonyms:
  • ROC-325
  • 9H-Thioxanthen-9-one, 1-[[2-[[2-[(7-chloro-4-quinolinyl)amino]ethyl]methylamino]ethyl]amino]-4-methyl-
  • ROC325;ROC 325
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
  • 1-{[2-({2-[(7-chloroquinolin-4-yl)amino]ethyl}(methyl)amino)ethyl]amino}-4-methyl-9H-thioxanthen-9-one

    CAS:
    Formula:C28H27ClN4OS
    Purity:98%
    Color and Shape:Solid
    Molecular weight:503.0582

    Ref: IN-DA01EOQM

    5mg
    170.00€
    10mg
    202.00€
    25mg
    287.00€
    100mg
    To inquire
    500mg
    To inquire
  • ROC-325

    CAS:
    ROC-325
    Purity:≥98%
    Molecular weight:503.06g/mol

    Ref: 54-BUP02036

    5mg
    74.00€
    10mg
    122.00€
    25mg
    240.00€
    50mg
    367.00€
    100mg
    559.00€
    200mg
    809.00€
  • ROC 325

    CAS:
    <p>ROC 325 is a novel fatty acid amide. It has been shown to have anticancer activity in vitro and in vivo, as well as an ability to inhibit tumor growth. ROC 325 is also able to induce autophagy, which may be due to its ability to inhibit protein synthesis. The drug can also be used for the treatment of infectious diseases or metabolic disorders, although it is not known whether it can be used in combination with other drugs. ROC 325 has shown no potential for interaction with anticancer treatments such as chemotherapy or radiation therapy and does not show any signs of toxicity in animal models.</p>
    Formula:C28H27ClN4OS
    Purity:Min. 95%
    Molecular weight:503.06 g/mol

    Ref: 3D-JZC14126

    25mg
    1,032.00€
    50mg
    1,353.00€
    100mg
    2,108.00€
  • ROC-325

    CAS:
    <p>ROC-325: orally active autophagy inhibitor with anticancer effects, induces kidney cancer cell death; selective action.</p>
    Formula:C28H27ClN4OS
    Purity:99.26%
    Color and Shape:Solid
    Molecular weight:503.06